Cannabis for Crohn's Disease: Systematic Review Shows Efficacy in Improvement
Meta-analysis reveals that cannabis may increase remission rates of Crohn's disease

A new meta-analysis of randomized clinical trials evaluated the efficacy and safety of cannabis in treating Crohn's disease (CD). The study was conducted by Pakistani researchers and published this year in the Irish Medical Science Journal. Conducted following the 2020 PRISMA guidelines and registered in PROSPERO, it analyzed data from multiple studies comparing cannabis to placebo or standard therapy.
Cannabis and Crohn's Disease Relief
The analysis showed that patients treated with cannabis had significantly higher rates of clinical improvement after eight weeks of use, with low heterogeneity among the studies analyzed. This finding suggests that the substance may be a promising therapeutic alternative for controlling CD.
Impacts on Quality of Life
Despite the positive results in remission, the research indicated that the quality of life reported by patients treated with cannabis was lower than that of the placebo group. Additionally, there was no statistically significant reduction in serum levels of C-reactive protein (CRP), a relevant inflammatory marker in CD.
Receive news and exclusive content about the cannabis universe:
Newsletter: Sign up and be the first to know everything!
WhatsApp and Telegram: News directly to your phone.
And more:
Follow Sechat on your favorite network!
Instagram | X | Linkedin | Facebook | TikTok | LinkBio | Flipboard
Don't miss anything! Follow now and stay connected.
Brazilian Medicinal Cannabis Congress (BMCC) 2025
[Buy now]
Safety and Future Perspectives
The research highlights that, although cannabis shows potential in treating CD, broader and standardized studies are needed to validate its long-term efficacy and safety. The lack of consensus on its impacts on quality of life and inflammatory biomarkers reinforces the need for more clinical investigations.
The growing acceptance of medicinal cannabis use motivates new research to clarify its role in treating inflammatory bowel diseases, offering better therapeutic options to patients.
Read more:
- Crohn's Disease Can Be Treated with Medicinal Marijuana
- Patient Used 70 Pills a Day Until Finding Medicinal Marijuana
